COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease (AADC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01973543
Recruitment Status : Completed
First Posted : October 31, 2013
Last Update Posted : March 3, 2020
University of California, San Francisco
Veristat, Inc.
Feinstein Institute for Medical Research
Oregon Health and Science University
Voyager Therapeutics
Information provided by (Responsible Party):
Neurocrine Biosciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 24, 2020
Actual Study Completion Date : January 24, 2020